Prostate Cancer Survival Hits 98% With Personalized Care

Memorial Sloan Kettering Cancer Center is transforming prostate cancer treatment with personalized approaches that are saving more lives while reducing side effects.

The 10-year survival rate has reached 98% thanks to advances in screening, targeted therapies, and knowing when careful monitoring works better than immediate treatment.